Winning multiregional approvals in a diverse dermatology landscape

As dermatology programs grow increasingly global, navigating diverse regulatory expectations becomes ever more complex. While certain requirements align, significant differences remain between agencies such as the FDA, EMA, and Asia Pacific (APAC) authorities (e.g. NMPA, PMDA, CDSCO) – particularly regarding demands for local data and the nuances of data standards and submission processes.

This paper provides clarity on these evolving requirements, highlighting where strategies must adapt to meet regional expectations, and underscoring that regulatory planning and execution must go hand in hand to ensure successful approval across all markets.